Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-2) Trial - THE CHART-2 TRIAL
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT02317458
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 400 participants
- Sponsor
- Celyad Oncology SA
- Registry
-
NCT02317458
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02317458. Randomized; quadruple masking; primary purpose treatment. Start 2017-06 (registry gives no type); primary completion 2020-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-2) Trial - THE CHART-2 TRIAL
- Acronym
- CHART-2
- Condition
- Heart Failure
- Intervention (Biological)
- Experimental
- Intervention (Biological)
- Sham comparator
- Lead sponsor
- Celyad Oncology SA
Record details
- Record id
cardio:ct-nct02317458- Content hash
0d84ff2bb9425b83535512ef7d457139fcadd00057cc3c2311a73c04866eddef